The prospect of hemoglobin-based blood substitutes: Still a long stony road to go.
作者信息
Bone Hans-Georg, Westphal Martin
出版信息
Crit Care Med. 2005 Mar;33(3):694-5. doi: 10.1097/01.ccm.0000155997.28186.e8.
Abstract
摘要
相似文献
1
The prospect of hemoglobin-based blood substitutes: Still a long stony road to go.
Crit Care Med. 2005 Mar;33(3):694-5. doi: 10.1097/01.ccm.0000155997.28186.e8.
2
Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock.
Crit Care Med. 2005 Mar;33(3):629-37. doi: 10.1097/01.ccm.0000156295.48075.49.
3
The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents.
Intensive Care Med. 2003 Mar;29(3):347-9. doi: 10.1007/s00134-003-1637-y.
4
Blood substitutes: the future is now.
J Am Coll Surg. 2003 Jan;196(1):1-17. doi: 10.1016/s1072-7515(02)01704-0.
5
Safeguarding patients in clinical trials with high mortality rates.
Am J Respir Crit Care Med. 2001 Jul 15;164(2):190-2. doi: 10.1164/ajrccm.164.2.2011028.
6
Effects of Diaspirin Crosslinked Hemoglobin (DCLHb) on microcirculation and local tissue pO2 of striated skin muscle following resuscitation from hemorrhagic shock.
Artif Cells Blood Substit Immobil Biotechnol. 2006;34(5):455-71. doi: 10.1080/10731190600769008.
7
Hemoglobin-based red blood cell substitutes.
Artif Organs. 2004 Sep;28(9):789-94. doi: 10.1111/j.1525-1594.2004.07394.x.
8
Counterintuitive red blood cell substitute--polyethylene glycol-modified human hemoglobin.
Crit Care Med. 2003 Jun;31(6):1882-4. doi: 10.1097/01.CCM.0000069341.90159.C7.
9
Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis.
Crit Care Med. 2000 Jun;28(6):1889-98. doi: 10.1097/00003246-200006000-00034.
10
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial.
JAMA. 1999 Nov 17;282(19):1857-64. doi: 10.1001/jama.282.19.1857.
引用本文的文献
1
A bloodless revolution. A growing interest in artificial blood substitutes has resulted in new products that could soon improve transfusion medicine.
EMBO Rep. 2005 Aug;6(8):705-8. doi: 10.1038/sj.embor.7400494.
Zotero 插件